Using GLP-1 to increase insulin secretion while slowing down how fast your stomach empties food works in the following ways: Slowed digestion Reduced appetite Stabilized blood sugar & energy At Saving Face, every GLP-1 treatment is supported by expert oversight, baseline lab testing, and personalized nutrition guidance
Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: The STEP 8 randomized clinical trial
A plateau, typically defined as little or no weight change for eight to 12 weeks, is not a sign of failure but rather the body adapting to a lower weight
The FDA has announced a public advisory committee meeting later this summer to consider moving specific peptides to the 503A bulks list[1], which could reopen the door for licensed compounding pharmacies to prepare them
Retatrutide's glucagon arm produces more nausea than pure GLP-1 compounds, so stabilizing it first makes it much easier to tell where any new symptom is coming from
